BRAMPTON, ON-- Medtronic of Canada today announced it has received Health Canada license for the Reveal LINQ Insertable Cardiac Monitor (ICM), the smallest implantable cardiac monitoring device ...
RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting DUBLIN - May 7, 2015 - Medtronic plc (MDT) today announced the first in-office implant ...
MINNEAPOLIS - February 19, 2014-Medtronic, Inc. (MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of its Reveal ...
DUBLIN, Medtronic plc today announced the first in-office implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study. The world's smallest cardiac ...
RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting DUBLIN - May 7, 2015 - Medtronic plc (MDT) today announced the first in-office implant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback